Journal profile · Clinical Neurology
Revue Neurologique
ISSN 0035-3787 · eISSN 2213-0004 · Elsevier Masson · FRANCE · Monthly · Founded 1893
Revue Neurologique: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.59; hybrid open access; APC about USD 3,620; median 104 days to acceptance (104 articles, last 24 months); community-reported acceptance: easy; 534 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Revue Neurologique is published by Elsevier Masson and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Peripheral Neuropathies and Disorders, Parkinson's Disease Mechanisms and Treatments and Epilepsy research and treatment, together about 22% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
The official publication of the Société Française de NeurologieThe first issue of the Revue Neurologique, featuring an original article by Jean-Martin Charcot, was published on February 28th, 1893. Six years later, the French Society of Neurology (SFN) adopted this journal as its official publication in the year of its foundation, 1899. The Revue Neurologique was published throughout the 20th century without interruption and is indexed in all international databases (including Current Contents, Pubmed, Scopus). Ten annual issues provide original peer-reviewed clinical and research articles, and review articles giving up-to-date insights in all areas of neurology. The Revue Neurologique also publishes guidelines and recommendations. The Revue Neurologique publishes original articles, brief reports, general reviews, editorials, and letters to the editor as well as correspondence concerning articles previously published in the journal in the correspondence column.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Philippe CouratierPublisher website
Editorial board by country: none in mainland China; most named France 32, United States 4, Switzerland 3 (39 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Peripheral Neuropathies and DisordersMedicine8.2%
- Parkinson's Disease Mechanisms and TreatmentsMedicine7.3%
- Epilepsy research and treatmentMedicine6.5%
- Acute Ischemic Stroke ManagementMedicine6.2%
- Health, Medicine and SocietyHealth Professions5.9%
- Multiple Sclerosis Research StudiesMedicine5.7%
- Botulinum Toxin and Related Neurological DisordersMedicine5.1%
- Genetic Neurodegenerative DiseasesNeuroscience4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedCurrent ContentsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.59LetPub ·
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 4.3LetPub ·
- CiteScore (publisher)
- 4.3Publisher website ·
- SJR 2026-06
- 0.76LetPub ·
- SNIP 2026-06
- 0.91LetPub ·
- h-index
- 41LetPub ·
- h-index
- 69OpenAlex ·
- i10-index
- 1,180OpenAlex ·
- 2-year mean citedness
- 0.57OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 26.56%LetPub ·
Volume
- Articles per year
- 103LetPub ·
Articles by year OpenAlex count · 12,475 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 497 | 74 | 27 |
| 2025 | 534 | 67 | 215 |
| 2024 | 513 | 95 | 637 |
| 2023 | 604 | 126 | 1,165 |
| 2022 | 596 | 111 | 1,133 |
| 2021 | 601 | 124 | 2,412 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
104 daysMedian, submission to acceptance · P25–P75 62 days – 191 days
- Acceptance to online
- median 33 days (104 articles)
- Submission to online
- median 140 days
- Sample
- 104 articles with submission and acceptance dates (258 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 14 daysPublisher website ·
- First decision after review
- 54 daysPublisher website ·
- Submission to acceptance
- 94 daysPublisher website ·
- Acceptance to publication
- 36 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,620 / EUR 3,300 / GBP 2,900 / JPY 448,990 | — | — | |
| Publisher website | USD 3,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Cover letter
- Required
Article types accepted4, with length limits
- editorialEditorials should not exceed 4 typewritten double-spaced pages (1 500 words). Tables and figures are not to be used, and a summary is not required. Use no more …main text ≤ 500 words · references ≤ 15
- letters to the editorThis section publishes short clinical cases. There may be no more than six authors. The letter does not include a summary or key words and the text cannot excee…main text ≤ 500 words
- review articleThe length of leading articles should not exceed 10-25 typewritten double-spaced pages, with an abstract and keywords. There is no limit for the number of table…Length not stated
- viewpointThese papers may address any topic in neurology and are not linked to a specific article. They should not include the findings of new research or data that have…main text ≤ 1,200 words · references ≤ 7
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of one independent expert reviewer to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Masson
- Country or region
- FRANCE
- Language
- French
- Frequency
- Monthly
- Founded
- 1893
- ISSN
- 0035-3787
- Electronic ISSN
- 2213-0004
- Society / sponsor
- Société Française de Neurologie
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Revue Neurologique
What CAS zone is Revue Neurologique in?
In the 2025 upgraded edition of the CAS Journal Ranking, Revue Neurologique is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Revue Neurologique?
The latest impact factor listed by LetPub is 2.59; CiteScore 4.3, h-index 69.
How long does peer review take at Revue Neurologique?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 62–191 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Revue Neurologique based?
Of the 39 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (32), United States (4) and Switzerland (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Revue Neurologique?
According to LetPub and DOAJ records, Revue Neurologique is indexed in SCIE and Scopus. The journal's website also lists PubMed and Current Contents; that list has not been checked against each database.
Is Revue Neurologique open access, and what is the APC?
Revue Neurologique is a hybrid journal. For open-access publication: APC about USD 3,620.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .